Supplementary Data from Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor–Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002)

Autor: Zhong-Yu Yuan, Jia-Jia Huang, Shu-Sen Wang, Yong-Yi Zhong, Xin An, Cong Xue, Kui-Kui Jiang, Ruo-Xi Hong, Wen Xia, Ying Guo, Fei Xu, Xin-Mei Liu, Heng Huang, An-Qing Zhang, Le-Hong Zhang, Yuan-Qi Zhang, Zhi-Yong Wu, Ying Lin, Yan-Xia Shi, Jian-Li Zhao, Xi-Wen Bi, Xin Hua
Rok vydání: 2023
DOI: 10.1158/1078-0432.22486484
Popis: Supplementary Data from Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor–Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002)
Databáze: OpenAIRE